Novel GLP-1 Drug on Attack Path Against Very High Triglycerides

By News Health
1 hour Ago

(MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed.
One Chinese cohort had triglycerides slashed from around 800 mg/dL at baseline…

Source link : https://www.medpagetoday.com/meetingcoverage/aha/118386

Author :

Publish date : 2025-11-08 14:30:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Navigating the Skin-Related Variants of Lupus

Disease of 1,000 Faces Shows How Science Is Tackling Immunity's Dark Side

Artificial Light at Night May Raise CVD Risk

Trial Patient Dies After Receiving CRISPR Gene Therapy

Better Therapy, Care in Advanced Breast Cancer Has Led to Longer Survival

James Watson, Co-Discoverer of the Double-Helix Shape of DNA, Has Died at Age 97